Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633902
Status:
RECRUITING
Last Update Posted:
2022-12-06
First Post:
2020-11-12
Brief Title:
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination HR Mutation
Sponsor:
Organization:
California Pacific Medical Center Research Institute